Evidence map›Paper›PMID 38687874›Full record

ArticleSchizophrenia bulletin2024

Striatal Functional Hypoconnectivity in Patients With Schizophrenia Suffering From Negative Symptoms, Longitudinal Findings.

Tal Geffen, Samyogita Hardikar, Jonathan Smallwood, Mariia Kaliuzhna, Fabien Carruzzo, Kerem Böge, Marco Matthäus Zierhut, Stefan Gutwinski, Teresa Katthagen, Stephan Kaiser and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Schizophrenia bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tal GeffenDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center (NCRC), Campus Mitte, Berlin, Germany.
Samyogita HardikarDepartment of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Jonathan SmallwoodDepartment of Psychology, Queen's University, Kingston, ON, Canada.
Mariia KaliuzhnaClinical and Experimental Psychopathology Laboratory, University of Geneva, Faculty of Medicine, Geneva, Switzerland.
Fabien CarruzzoClinical and Experimental Psychopathology Laboratory, University of Geneva, Faculty of Medicine, Geneva, Switzerland.
Kerem BögeDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Marco Matthäus ZierhutDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.ORCID 0000-0003-3109-9050
Stefan GutwinskiDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center (NCRC), Campus Mitte, Berlin, Germany.
Teresa KatthagenDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center (NCRC), Campus Mitte, Berlin, Germany.ORCID 0000-0002-7537-4192
Stephan KaiserAdult Psychiatry Division, Department of Psychiatry, Geneva University Hospital, Geneva, Switzerland.
Florian SchlagenhaufDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center (NCRC), Campus Mitte, Berlin, Germany.

Funding

German Research Foundation SCHL 1969-3/1Heisenberg Program SCHL 1969-4/1-5/1National Science Foundation 10001CL_169783
6 · The paper itself

Abstract

backgroundNegative symptoms in schizophrenia (SZ), such as apathy and diminished expression, have limited treatments and significantly impact daily life. Our study focuses on the functional division of the striatum: limbic-motivation and reward, associative-cognition, and sensorimotor-sensory and motor processing, aiming to identify potential biomarkers for negative symptoms. STUDY

designThis longitudinal, 2-center resting-state-fMRI (rsfMRI) study examines striatal seeds-to-whole-brain functional connectivity. We examined connectivity aberrations in patients with schizophrenia (PwSZ), focusing on stable group differences across 2-time points using intra-class-correlation and associated these with negative symptoms and measures of cognition. Additionally, in PwSZ, we used negative symptoms to predict striatal connectivity aberrations at the baseline and used the striatal aberration to predict symptoms 9 months later. STUDY

resultsA total of 143 participants (77 PwSZ, 66 controls) from 2 centers (Berlin/Geneva) participated. We found sensorimotor-striatum and associative-striatum hypoconnectivity. We identified 4 stable hypoconnectivity findings over 3 months, revealing striatal-fronto-parietal-cerebellar hypoconnectivity in PwSZ. From those findings, we found hypoconnectivity in the bilateral associative striatum with the bilateral paracingulate-gyrus and the anterior cingulate cortex in PwSZ. Additionally, hypoconnectivity between the associative striatum and the superior frontal gyrus was associated with lower cognition scores in PwSZ, and weaker sensorimotor striatum connectivity with the superior parietal lobule correlated negatively with diminished expression and could predict symptom severity 9 months later.

conclusionsImportantly, patterns of weaker sensorimotor striatum and superior parietal lobule connectivity fulfilled the biomarker criteria: clinical significance, reflecting underlying pathophysiology, and stability across time and centers.

Indexed as

Corpus StriatumMagnetic Resonance ImagingSchizophreniaAdultConnectomeFemaleGyrus CinguliHumansLongitudinal StudiesMaleMiddle AgedNerve NetParietal LobeYoung Adultnegative-symptomsresting-state-functional-connectivityrsfMRIschizophreniastriatum

Identifiers

PMID38687874
PMCPMC11548920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.